| Special Facial Prosthetics Llc | |
| 229 Nw 9th St, Oklahoma City, Oklahoma 73102 | |
| (405) 620-0880 |
| Name | Special Facial Prosthetics Llc |
|---|---|
| Organization Name | Specialty Facial Prosthetics Llc |
| Location | 229 Nw 9th St, Oklahoma City, Oklahoma 73102 |
| Type | DME Supplier - Customized Equipment |
| Phone | (405) 620-0880 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
In today's headlines, reports on the latest developments related to the 'super committee's' deliberations, an appeals court issues a health law decision and results from yesterday's elections.
A team from the UPV/EHU-University of the Basque Country came across a mutation of the LRRK2 gene in 2004, which is particularly prevalent among the population of Gipuzkoa. It is the R1441G mutation and is known as the Basque mutation.
Breastfeeding from birth to six months or a year can reduce deaths among children under five by 13 percent, a fact UNICEF is highlighting during World Breastfeeding Week, which runs through August 7, the International Business Times reports.
AstraZeneca today announced the U.S. Food and Drug Administration (FDA) approved CRESTOR® (rosuvastatin calcium) for use in pediatric patients ages 10-17 with heterozygous familial hypercholesterolemia (HeFH) when diet therapy fails to reduce elevated cholesterol. HeFH, a genetic disease, is characterized by high LDL cholesterol (the "bad" cholesterol) and increased risk of early cardiovascular disease.
› Verified 3 days ago
| NPI Number | 1760963276 |
| Organization Name | SPECIALTY FACIAL PROSTHETICS LLC |
| Type | DME Supplier - Customized Equipment |
| Address | 229 Nw 9th St Ste 107, Oklahoma City, OK 73102 |
| Phone Number | 405-620-0880 |
News Archive
In today's headlines, reports on the latest developments related to the 'super committee's' deliberations, an appeals court issues a health law decision and results from yesterday's elections.
A team from the UPV/EHU-University of the Basque Country came across a mutation of the LRRK2 gene in 2004, which is particularly prevalent among the population of Gipuzkoa. It is the R1441G mutation and is known as the Basque mutation.
Breastfeeding from birth to six months or a year can reduce deaths among children under five by 13 percent, a fact UNICEF is highlighting during World Breastfeeding Week, which runs through August 7, the International Business Times reports.
AstraZeneca today announced the U.S. Food and Drug Administration (FDA) approved CRESTOR® (rosuvastatin calcium) for use in pediatric patients ages 10-17 with heterozygous familial hypercholesterolemia (HeFH) when diet therapy fails to reduce elevated cholesterol. HeFH, a genetic disease, is characterized by high LDL cholesterol (the "bad" cholesterol) and increased risk of early cardiovascular disease.
› Verified 3 days ago
News Archive
In today's headlines, reports on the latest developments related to the 'super committee's' deliberations, an appeals court issues a health law decision and results from yesterday's elections.
A team from the UPV/EHU-University of the Basque Country came across a mutation of the LRRK2 gene in 2004, which is particularly prevalent among the population of Gipuzkoa. It is the R1441G mutation and is known as the Basque mutation.
Breastfeeding from birth to six months or a year can reduce deaths among children under five by 13 percent, a fact UNICEF is highlighting during World Breastfeeding Week, which runs through August 7, the International Business Times reports.
AstraZeneca today announced the U.S. Food and Drug Administration (FDA) approved CRESTOR® (rosuvastatin calcium) for use in pediatric patients ages 10-17 with heterozygous familial hypercholesterolemia (HeFH) when diet therapy fails to reduce elevated cholesterol. HeFH, a genetic disease, is characterized by high LDL cholesterol (the "bad" cholesterol) and increased risk of early cardiovascular disease.
› Verified 3 days ago
180 Medical Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8516 Nw Expressway, Oklahoma City, Oklahoma 73162 Phone: (877) 688-2729 | |
Rehab Medical Supply Type: Medicare Supplier Location: 4601 N May Ave, Oklahoma City, Oklahoma 73112 Phone: (405) 947-6162 | |
Accente, Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 11629 S Western Ave, Oklahoma City, Oklahoma 73170 Phone: (405) 703-3143 | |
Accredo Health Group, Inc. Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4901 W Reno Ave, Oklahoma City, Oklahoma 73127 Phone: (405) 942-3961 | |
Aerocare Home Medical Equipment Inc Type: DME Supplier - Oxygen Equipment & Supplies Location: 6125 W Reno Ave, Ste 100, Oklahoma City, Oklahoma 73127 Phone: (405) 943-2200 |